rs111750275
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001195263.2(PDZD7):āc.2538G>Cā(p.Gly846Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000313 in 1,535,484 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0016 ( 0 hom., cov: 32)
Exomes š: 0.00017 ( 3 hom. )
Consequence
PDZD7
NM_001195263.2 synonymous
NM_001195263.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.483
Genes affected
PDZD7 (HGNC:26257): (PDZ domain containing 7) This gene encodes a ciliary protein homologous to proteins which are mutated in Usher syndrome patients, and mutations and translocations involving this gene have been associated with two types of Usher syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 10-101010351-C-G is Benign according to our data. Variant chr10-101010351-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 164936.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-101010351-C-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.483 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00162 (247/152294) while in subpopulation AFR AF= 0.0051 (212/41568). AF 95% confidence interval is 0.00454. There are 0 homozygotes in gnomad4. There are 112 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 3 AR,Digenic gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDZD7 | ENST00000619208.6 | c.2538G>C | p.Gly846Gly | synonymous_variant | 15/17 | 5 | NM_001195263.2 | ENSP00000480489.1 | ||
PDZD7 | ENST00000474125.7 | n.*2485G>C | non_coding_transcript_exon_variant | 11/13 | 2 | ENSP00000474447.1 | ||||
PDZD7 | ENST00000474125.7 | n.*2485G>C | 3_prime_UTR_variant | 11/13 | 2 | ENSP00000474447.1 |
Frequencies
GnomAD3 genomes AF: 0.00160 AC: 244AN: 152176Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
244
AN:
152176
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000328 AC: 45AN: 137142Hom.: 0 AF XY: 0.000228 AC XY: 17AN XY: 74542
GnomAD3 exomes
AF:
AC:
45
AN:
137142
Hom.:
AF XY:
AC XY:
17
AN XY:
74542
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000169 AC: 234AN: 1383190Hom.: 3 Cov.: 90 AF XY: 0.000135 AC XY: 92AN XY: 682564
GnomAD4 exome
AF:
AC:
234
AN:
1383190
Hom.:
Cov.:
90
AF XY:
AC XY:
92
AN XY:
682564
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00162 AC: 247AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.00150 AC XY: 112AN XY: 74470
GnomAD4 genome
AF:
AC:
247
AN:
152294
Hom.:
Cov.:
32
AF XY:
AC XY:
112
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 17, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 10, 2020 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 30, 2012 | Gly846Gly in Exon 15 of PDZD7: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 50.0% (1/2) of chromo somes from a population in the dbSNP database (http://www.ncbi.nlm.nih.gov/proje cts/SNP; rs111750275). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at